Your browser doesn't support javascript.
loading
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis.
Magni, M; Di Nicola, M; Patti, C; Scimè, R; Mulè, A; Rambaldi, A; Intermesoli, T; Viero, P; Tarella, C; Gueli, A; Bergui, L; Trentin, L; Barzan, A; Benedetti, F; Ambrosetti, A; Di Raimondo, F; Chiarenza, A; Parvis, G; Billio, A; Attolico, I; Olivieri, A; Montanari, M; Carlo-Stella, C; Matteucci, P; Devizzi, L; Guidetti, A; Viviani, S; Valagussa, P; Gianni, A M.
Afiliação
  • Magni M; Division of Medical Oncology, Bone Marrow Transplantation Unit, Fondazione IRCCS, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
  • Di Nicola M; Division of Medical Oncology, Bone Marrow Transplantation Unit, Fondazione IRCCS, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
  • Patti C; Department of Hematology I, Azienda Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
  • Scimè R; Department of Hematology I, Azienda Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
  • Mulè A; Department of Hematology I, Azienda Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
  • Rambaldi A; Unit of Hematology, Ospedali Riuniti di Bergamo, Bergamo, Italy.
  • Intermesoli T; Unit of Hematology, Ospedali Riuniti di Bergamo, Bergamo, Italy.
  • Viero P; Unit of Hematology, Ospedali Riuniti di Bergamo, Bergamo, Italy.
  • Tarella C; S.C.D.U. Hematology and Cellular Therapy, A.O. Ord. Mauriziano-Umberto I, Turin, Italy.
  • Gueli A; S.C.D.U. Hematology and Cellular Therapy, A.O. Ord. Mauriziano-Umberto I, Turin, Italy.
  • Bergui L; Department of Hematology, A.O. S. Giovanni Battista Molinette, Turin, Italy.
  • Trentin L; Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy.
  • Barzan A; Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padua, Italy.
  • Benedetti F; Department of Hematology, Policlinico GB Rossi, Verona, Italy.
  • Ambrosetti A; Department of Hematology, Policlinico GB Rossi, Verona, Italy.
  • Di Raimondo F; Division of Hematology, Ospedale Ferrarotto, AOU Policlinico-OVE, University of Catania, Catania, Italy.
  • Chiarenza A; Division of Hematology, Ospedale Ferrarotto, AOU Policlinico-OVE, University of Catania, Catania, Italy.
  • Parvis G; Division of Internal Medicine and Haematology, Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy.
  • Billio A; Hematology Department, San Maurizio Regional Hospital, Bolzano, Italy.
  • Attolico I; Division of Haematology, Ospedale San Carlo, Potenza, Italy.
  • Olivieri A; Division of Haematology, Ospedale San Carlo, Potenza, Italy.
  • Montanari M; Division of Haematology, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Ancona, Italy.
  • Carlo-Stella C; 1] Medical Oncology and Hematology Unit, Humanitas Cancer Center, Istituto Clinico Humanitas, IRCCS, Rozzano, Milan, Italy [2] Chair of Oncology, University of Milan, Milan, Italy.
  • Matteucci P; Division of Medical Oncology, Bone Marrow Transplantation Unit, Fondazione IRCCS, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
  • Devizzi L; Division of Medical Oncology, Bone Marrow Transplantation Unit, Fondazione IRCCS, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
  • Guidetti A; Division of Medical Oncology, Bone Marrow Transplantation Unit, Fondazione IRCCS, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
  • Viviani S; Division of Medical Oncology, Bone Marrow Transplantation Unit, Fondazione IRCCS, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
  • Valagussa P; Fondazione Michelangelo, Milan, Italy.
  • Gianni AM; 1] Division of Medical Oncology, Bone Marrow Transplantation Unit, Fondazione IRCCS, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy [2] Chair of Oncology, University of Milan, Milan, Italy.
Bone Marrow Transplant ; 49(4): 485-91, 2014 Apr.
Article em En | MEDLINE | ID: mdl-24442244
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Itália